Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 100,177	$ 63,888
Accounts receivable, net	43,830	38,790
Inventory, net	18,887	11,312
Prepaid expenses and other current assets	5,754	3,769
Total current assets	168,648	117,759
Property and equipment, net	1,485	2,075
Goodwill	2,715	2,715
License and distribution rights, net	55,109	60,309
Other intangible assets, net	0	47
Total assets	227,957	182,905
Current liabilities:
Accounts payable and accrued liabilities	53,409	53,993
Total current liabilities	53,409	53,993
Notes payable, net	78,363	58,568
Other long-term liabilities	300	580
Total liabilities	132,072	113,141
Commitments and contingencies (Note 9)
Stockholders’ equity:
Preferred Stock, 5,000,000 shares authorized; Series A Non-Voting Convertible Preferred Stock. $0.001 par value, 0 and 2,093,155 shares outstanding at September 30, 2020 and December 31, 2019, respectively; Series B Non-Voting Convertible Preferred Stock, $0.001 par value, 443 and 618 shares outstanding at September 30, 2020 and December 31, 2019, respectively.	0	2
Common Stock, $0.001 par value; 235,000,000 and 175,000,000 shares authorized at September 30, 2020 and December 31, 2019, respectively; 101,126,452 and 96,189,074 shares issued; 101,110,961 and 96,173,583 shares outstanding at September 30, 2020 and December 31, 2019, respectively.	100	96
Additional paid-in capital	446,910	436,306
Treasury stock, at cost, 15,491 shares, as of September 30, 2020 and December 31, 2019.	(47)	(47)
Accumulated deficit	(351,078)	(366,593)
Total stockholders’ equity	95,885	69,764
Total liabilities and stockholders’ equity	$ 227,957	$ 182,905
Common Stock, shares authorized (in shares)	235,000,000	175,000,000